When is the anticipated generic onglyza release date?

There isn’t a publicly announced release date for a generic version of Onglyza (saxagliptin). Generic entry depends on patent status, any exclusivities, and potential legal settlements, and these details can change over time.

What to check for the latest info (US-focused):
- FDA Orange Book: look up saxagliptin/Onglyza to see current patent numbers and expiration dates, plus any data or market exclusivities listed.
- Any settlements or court rulings that could affect timing.
- Company communications (AstraZeneca/BMS) for updates on patent litigation or settlements.

If you’re asking about a region other than the US, let me know which country, and I can point you to the regional patent/exclusivity sources.

If you want, I can help interpret the latest Orange Book entry or summarize what the key dates mean for when a generic might appear.